Free Trial
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis

Organicell Regenerative Medicine logo
$2.37 +0.35 (+17.33%)
As of 06/20/2025

About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR)

Key Stats

Today's Range
$2.00
$2.40
50-Day Range
$1.85
$2.90
52-Week Range
$0.04
$0.63
Volume
8,942 shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

BPSR Stock News Headlines

ZEOX Zeo ScientifiX, Inc.
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Zeo ScientifiX, Inc. (ZEOX)
Organicell Regenerative Medicine Inc (OCELD)
OCELD Organicell Regenerative Medicine, Inc.
See More Headlines

BPSR Stock Analysis - Frequently Asked Questions

Organicell Regenerative Medicine's stock was trading at $3.11 at the beginning of 2025. Since then, BPSR shares have decreased by 23.8% and is now trading at $2.37.
View the best growth stocks for 2025 here
.

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organicell Regenerative Medicine investors own include Aurora Cannabis (ACB), NVIDIA (NVDA), 22nd Century Group (XXII), BioNTech (BNTX), Evofem Biosciences (EVFM), Inseego (INSG) and American Lithium (LIACF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BPSR
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:BPSR) was last updated on 6/25/2025 by MarketBeat.com Staff
From Our Partners